Samsung Biologics will acquire Biogen’s stake in Samsung Bioepis for $2.3 billion to accelerate growth in biosimilars and novel therapeutic research and development.
Under the terms of the...
Pfizer recently announced that it will appoint William Pao, MD, PhD, as executive vice president and chief development officer.
Effective March 2022, Pao will replace Rod Mackenzie, who recently...
Eli Lilly and Company recently announced plans to invest over $1 billion to create a new manufacturing site and boost access to medicine in Concord, North Carolina.
The facility will utilize the...
GSK recently appointed Tony Wood as chief executive officer (CSO), replacing current CSO Hal Barron.
Wood, a highly respected scientist and one of the world’s pre-eminent chemists, has over 30...
Pfizer and Biohaven recently completed a collaboration transaction to commercialize small molecule migraine drugs, rimegepant and zavegepant, outside the US.
Rimegepant, commercialized as Nurtex ODT...
Sanofi and Exscientia recently entered into a research collaboration and license agreement to develop 15 novel small molecule drug candidates across oncology and immunology.
The companies will...
Eli Lilly & Company recently acquired exclusive rights to Entos Pharmaceuticals’ Fusogenix nucleic acid delivery technology to develop nucleic acid products.
The companies will initially...
As big pharma looks to advance its pipelines of innovative drugs and digital measures, industry cooperation is crucial.
In recent years, pharmaceutical companies have embraced a more collaborative way...
Hackensack Meridian Health recently announced its support of the clinical development of a highly-differentiated immuno-oncology platform from Alloplex Biotherapeutics.
This investment is...
More than nine in 10 executives plan to implement a more robust digital supply chain visibility (SCV) solution over the next 12 months, according to a new report from FourKites.
The Pharmaceutical...
Bristol Myers Squibb and clinical-stage biopharmaceutical company Immatics recently entered into a license, development, and commercialization agreement for the bispecific T-cell candidate,...
AstraZeneca recently entered into a global development and commercialization agreement with Ionis Pharmaceuticals for transthyretin amyloidosis medication, eplontersen.
Eplontersen is a...
Moderna and Carnegie Mellon University (CMU) recently launched its Artificial Intelligence (AI) Academy to bring mRNA therapies to patients.
The initiative will bring an immersive learning experience...
GSK and the University of Oxford recently entered into a five-year collaboration to improve the success and speed of research and development of new medicines and unravel mechanisms of disease.
GSK...
Pfizer and Amazon Web Services (AWS) recently collaborated to create innovative, cloud-based solutions to improve drug development, manufacturing, and distribution for clinical trials.
The...
GSK recently appointed Phil Dormitzer, MD, PhD, as global head of vaccines research and development and a member of the vaccines leadership team.
Previously, Dormitzer was vice president and chief...
President Joe Biden recently nominated Robert Califf as head of FDA, according to multiple news sources.
Califf previously served as FDA commissioner at the end of the Obama administration from 2016...
Gilead and Merck recently announced the start of a Phase 2 clinical study evaluating a combination HIV treatment regimen in adults living with the disease.
The open-label study will evaluate the...
Cerner recently launched a new operating unit, Cerner Enviza, that offers data-driven solutions and research services to clarify multi-dimensional data through real-world evidence and...
